Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 3873K) PDF+supp data (4642K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lee, P. Y. Articles by Reeves, W. H. Search for Related Content PubMed PubMed Citation Articles by Lee, P. Y. Articles by Reeves, W. H. Social Bookmarking                            What's this?

TLR7-dependent and FcR-independent production of type I interferon in experimental mouse lupus

¹ Division of Rheumatology and Clinical Immunology and Center for Autoimmune Disease and ² Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610
³ Laboratory of Host Defense, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan
⁴ Division of Rheumatology and Infectious Diseases, Department of Internal Medicine, Fujita Health University, Toyoake, Aichi-Ken 470-1192, Japan
⁵ Department of Molecular Cell Biology, Free University Medical Center, 1007MB Amsterdam, Netherlands

CORRESPONDENCE Pui Y. Lee: puilee05{at}ufl.edu

Increased type I interferon (IFN-I) production and IFN-stimulated gene (ISG) expression are linked to the pathogenesis of systemic lupus erythematosus (SLE). Although the mechanisms responsible for dysregulated IFN-I production in SLE remain unclear, autoantibody-mediated uptake of endogenous nucleic acids is thought to play a role. 2,6,10,14-tetramethylpentadecane (TMPD; also known as pristane) induces a lupus-like disease in mice characterized by immune complex nephritis with autoantibodies to DNA and ribonucleoproteins. We recently reported that TMPD also causes increased ISG expression and that the development of the lupus is completely dependent on IFN-I signaling (Nacionales, D.C., K.M. Kelly-Scumpia, P.Y. Lee, J.S. Weinstein, R. Lyons, E. Sobel, M. Satoh, and W.H. Reeves. 2007. Arthritis Rheum. 56:3770–3783). We show that TMPD elicits IFN-I production, monocyte recruitment, and autoantibody production exclusively through a Toll-like receptor (TLR) 7– and myeloid differentiation factor 88 (MyD88)–dependent pathway. In vitro studies revealed that TMPD augments the effect of TLR7 ligands but does not directly activate TLR7 itself. The effects of TMPD were amplified by the Y-linked autoimmune acceleration cluster, which carries a duplication of the TLR7 gene. In contrast, deficiency of Fc receptors (FcRs) did not affect the production of IFN-I. Collectively, the data demonstrate that TMPD-stimulated IFN-I production requires TLR7/MyD88 signaling and is independent of autoantibody-mediated uptake of ribonucleoproteins by FcRs.

© 2008 Lee et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Lee, P. Y., Li, Y., Kumagai, Y., Xu, Y., Weinstein, J. S., Kellner, E. S., Nacionales, D. C., Butfiloski, E. J., van Rooijen, N., Akira, S., Sobel, E. S., Satoh, M., Reeves, W. H. (2009). Type I Interferon Modulates Monocyte Recruitment and Maturation in Chronic Inflammation. Am. J. Pathol. 175: 2023-2033 [Abstract] [Full Text]  
• Zhang, K., Kagan, D., DuBois, W., Robinson, R., Bliskovsky, V., Vass, W. C., Zhang, S., Mock, B. A. (2009). Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. Blood 114: 2952-2960 [Abstract] [Full Text]  
• Sim, D. L., Bagavant, H., Scindia, Y. M., Ge, Y., Gaskin, F., Fu, S. M., Deshmukh, U. S. (2009). Genetic Complementation Results in Augmented Autoantibody Responses to Lupus-Associated Antigens. J. Immunol. 183: 3505-3511 [Abstract] [Full Text]  
• Kono, D. H., Haraldsson, M. K., Lawson, B. R., Pollard, K. M., Koh, Y. T., Du, X., Arnold, C. N., Baccala, R., Silverman, G. J., Beutler, B. A., Theofilopoulos, A. N. (2009). Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 106: 12061-12066 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS